BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 37708662)

  • 21. Prognostic significance of peritoneal cytology in low-intermediate risk endometrial cancer.
    Scott SA; van der Zanden C; Cai E; McGahan CE; Kwon JS
    Gynecol Oncol; 2017 May; 145(2):262-268. PubMed ID: 28359690
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Significance of Malignant Peritoneal Cytology on Survival of Women with Uterine Sarcoma.
    Matsuo K; Matsuzaki S; Nusbaum DJ; Ki S; Chang EJ; Klar M; Roman LD
    Ann Surg Oncol; 2021 Mar; 28(3):1740-1748. PubMed ID: 33063261
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant Pelvic Radiation Therapy±Vaginal Brachytherapy in Patients With High-risk Stage I or Stage II Uterine Papillary Serous, Clear Cell, and High-grade Endometrioid Carcinoma.
    Nagar H; Yan W; Parashar B; Nori D; Chao KS; Christos P; Gupta D; Holcomb K; Caputo T; Wernicke AG
    Am J Clin Oncol; 2016 Aug; 39(4):335-9. PubMed ID: 27028349
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The prognostic significance of positive peritoneal cytology and adnexal/serosal metastasis in stage IIIA endometrial cancer.
    Havrilesky LJ; Cragun JM; Calingaert B; Alvarez Secord A; Valea FA; Clarke-Pearson DL; Berchuck A; Soper JT
    Gynecol Oncol; 2007 Feb; 104(2):401-5. PubMed ID: 17014898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Ten-year outcome including patterns of failure and toxicity for adjuvant whole abdominopelvic irradiation in high-risk and poor histologic feature patients with endometrial carcinoma.
    Stewart KD; Martinez AA; Weiner S; Podratz K; Stromberg JS; Schray M; Mitchell C; Sherman A; Chen P; Brabbins DA
    Int J Radiat Oncol Biol Phys; 2002 Oct; 54(2):527-35. PubMed ID: 12243832
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Positive peritoneal cytology is an independent risk-factor in early stage endometrial cancer.
    Garg G; Gao F; Wright JD; Hagemann AR; Mutch DG; Powell MA
    Gynecol Oncol; 2013 Jan; 128(1):77-82. PubMed ID: 23032094
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Stage IVB endometrial cancer confined to the abdomen: is chemotherapy superior to radiotherapy?
    Cirik DA; Karalok A; Ureyen I; Tasci T; Koc S; Turan T; Tulunay G
    Eur J Gynaecol Oncol; 2016; 37(2):226-31. PubMed ID: 27172750
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clear cell carcinomas of the ovary have poorer outcomes compared with serous carcinomas: Results from a single-center Taiwanese study.
    Ku FC; Wu RC; Yang LY; Tang YH; Chang WY; Yang JE; Wang CC; Jung SM; Lin CT; Chang TC; Chao A; Lai CH
    J Formos Med Assoc; 2018 Feb; 117(2):117-125. PubMed ID: 28389144
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prognosis and adjuvant chemotherapy for patients with positive peritoneal cytology in stage IA endometrial cancer.
    Kanno M; Yunokawa M; Nakabayashi M; Omi M; Ikki A; Mizusaki M; Nishimura M; Shimizu Y; Okamoto K; Tanaka Y; Fusegi A; Netsu S; Kurita T; Aoki Y; Tanigawa T; Matoda M; Okamoto S; Nomura H; Omatsu K; Sugiyama Y; Utsugi K; Takeshima N; Kanao H
    Sci Rep; 2022 Jan; 12(1):166. PubMed ID: 34997003
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Peritoneal cytology: a risk factor of recurrence for non-endometrioid endometrial cancer.
    Han KH; Park NH; Kim HS; Chung HH; Kim JW; Song YS
    Gynecol Oncol; 2014 Aug; 134(2):293-6. PubMed ID: 24854062
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Combination of adjuvant chemotherapy and radiotherapy is associated with improved survival at early stage type II endometrial cancer and carcinosarcoma.
    Sozen H; Çiftçi R; Vatansever D; Topuz S; Iyibozkurt AC; Bozbey HU; Yaşa C; Çali H; Yavuz E; Kucucuk S; Aydiner A; Salihoglu Y
    Aust N Z J Obstet Gynaecol; 2016 Apr; 56(2):199-206. PubMed ID: 26890292
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Postoperative chemotherapy significantly improves survival of elderly patients with stage IB-II non-small cell lung cancer: A population-based study.
    Liu W; Ma S; Shi P; Zhang Y; Li M
    Cancer Med; 2023 May; 12(10):11254-11263. PubMed ID: 37031456
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Adult Comorbidity Evaluation 27 score as a predictor of survival in endometrial cancer patients.
    Binder PS; Peipert JF; Kallogjeri D; Brooks RA; Massad LS; Mutch DG; Powell MA; Thaker PH; McCourt CK
    Am J Obstet Gynecol; 2016 Dec; 215(6):766.e1-766.e9. PubMed ID: 27457116
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The outcome of stage I-II clinically and surgically staged papillary serous and clear cell endometrial cancers when compared with endometrioid carcinoma.
    Cirisano FD; Robboy SJ; Dodge RK; Bentley RC; Krigman HR; Synan IS; Soper JT; Clarke-Pearson DL
    Gynecol Oncol; 2000 Apr; 77(1):55-65. PubMed ID: 10739691
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of adjuvant therapy in stage IA serous and clear cell uterine cancer: A multi-institutional pooled analysis.
    Qu XM; Velker VM; Leung E; Kwon JS; Elshaikh MA; Kong I; Logie NA; Mendez LC; van der Putten LJ; Donovan EK; Munkarah AR; Wiebe EM; Parra-Herran C; Warner A; Louie AV; D'Souza DP
    Gynecol Oncol; 2018 May; 149(2):283-290. PubMed ID: 29544706
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Influence of positive peritoneal cytology on prognostic factors and survival in early-stage endometrial cancer: a systematic review and meta-analysis.
    Lee B; Suh DH; Kim K; No JH; Kim YB
    Jpn J Clin Oncol; 2016 Aug; 46(8):711-7. PubMed ID: 27207885
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Early-stage clear cell ovarian cancer compared to high-grade histological subtypes: An outcome exploratory analysis in two oncology centers.
    Ceppi L; Grassi T; Galli F; Buda A; Aletti G; Lissoni AA; Adorni M; Garbi A; Colombo N; Bonazzi C; Landoni F; Fruscio R
    Gynecol Oncol; 2021 Jan; 160(1):64-70. PubMed ID: 33077259
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trends in peritoneal cytology evaluation at hysterectomy for endometrial cancer in the United States.
    Matsuo K; Klar M; Harter P; Miller H; Nusbaum DJ; Matsuzaki S; Roman LD; Wright JD
    Gynecol Oncol; 2021 Jun; 161(3):710-719. PubMed ID: 33726962
    [TBL] [Abstract][Full Text] [Related]  

  • 39. National patterns of care and cancer-specific outcomes of adjuvant treatment in patients with serous and clear cell endometrial carcinoma.
    Xiang M; English DP; Kidd EA
    Gynecol Oncol; 2019 Mar; 152(3):599-604. PubMed ID: 30551884
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter study comparing oncologic outcomes after lymph node assessment via a sentinel lymph node algorithm versus comprehensive pelvic and paraaortic lymphadenectomy in patients with serous and clear cell endometrial carcinoma.
    Schlappe BA; Weaver AL; McGree ME; Ducie J; Zahl Eriksson AG; Dowdy SC; Cliby WA; Glaser GE; Abu-Rustum NR; Mariani A; Leitao MM
    Gynecol Oncol; 2020 Jan; 156(1):62-69. PubMed ID: 31776037
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.